| Ryan Mark Rister, DO | |
|
1226 Dantignac St, Augusta, GA 30901-2788 | |
| (706) 922-0600 | |
| (706) 922-0604 |
| Full Name | Ryan Mark Rister |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 8 Years |
| Location | 1226 Dantignac St, Augusta, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306291877 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 86270 (Georgia) | Primary |
| 207Q00000X | Family Medicine | R6885 (Texas) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Christ Community Health Services Augusta, Inc. | 6608953633 | 20 |
News Archive
Genzyme, a Sanofi company, announced today that Health Canada has approved Lemtrada (alemtuzumab) for the management of adult patients with relapsing remitting multiple sclerosis, with active disease defined by clinical and imaging features, who have had an inadequate response to interferon beta or other disease-modifying therapies.
New research published on the preprint server bioRxiv* suggests S2-specific antibody responses are critical in recovering from mild to severe COVID-19 infection. Compared to patients who died within 28 days of their COVID-19 diagnosis, patients who produced a wide range of S2-specific responses were more likely to survive.
Contrary to common stereotypes, individuals with major mental disorders are more likely to become victims of violent crimes when they are experiencing an increase in symptoms than they are to commit crime, according to a new study by Brent Teasdale, an assistant professor of criminal justice at Georgia State University.
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
› Verified 7 days ago
| Entity Name | Christ Community Health Services Augusta, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174716989 PECOS PAC ID: 6608953633 Enrollment ID: O20080401000769 |
News Archive
Genzyme, a Sanofi company, announced today that Health Canada has approved Lemtrada (alemtuzumab) for the management of adult patients with relapsing remitting multiple sclerosis, with active disease defined by clinical and imaging features, who have had an inadequate response to interferon beta or other disease-modifying therapies.
New research published on the preprint server bioRxiv* suggests S2-specific antibody responses are critical in recovering from mild to severe COVID-19 infection. Compared to patients who died within 28 days of their COVID-19 diagnosis, patients who produced a wide range of S2-specific responses were more likely to survive.
Contrary to common stereotypes, individuals with major mental disorders are more likely to become victims of violent crimes when they are experiencing an increase in symptoms than they are to commit crime, according to a new study by Brent Teasdale, an assistant professor of criminal justice at Georgia State University.
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ryan Mark Rister, DO Po Box 2344, Augusta, GA 30903-2344 Ph: (706) 922-0600 | Ryan Mark Rister, DO 1226 Dantignac St, Augusta, GA 30901-2788 Ph: (706) 922-0600 |
News Archive
Genzyme, a Sanofi company, announced today that Health Canada has approved Lemtrada (alemtuzumab) for the management of adult patients with relapsing remitting multiple sclerosis, with active disease defined by clinical and imaging features, who have had an inadequate response to interferon beta or other disease-modifying therapies.
New research published on the preprint server bioRxiv* suggests S2-specific antibody responses are critical in recovering from mild to severe COVID-19 infection. Compared to patients who died within 28 days of their COVID-19 diagnosis, patients who produced a wide range of S2-specific responses were more likely to survive.
Contrary to common stereotypes, individuals with major mental disorders are more likely to become victims of violent crimes when they are experiencing an increase in symptoms than they are to commit crime, according to a new study by Brent Teasdale, an assistant professor of criminal justice at Georgia State University.
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
› Verified 7 days ago
Dr. Toya Hester Kelley, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1120 15th St, Augusta, GA 30912 Phone: 706-721-3157 | |
Dr. Daria Ravangard, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1120 15th St, Augusta, GA 30912 Phone: 706-721-6569 | |
Janis S. Coffin, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1120 15th St, Augusta, GA 30912 Phone: 706-721-4588 Fax: 706-721-7264 | |
Dr. William Robert Rout, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 963 Bennock Mill Dr., Augusta, GA 30906 Phone: 352-538-5899 | |
Racquel Puranda, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1120 15th St, Augusta, GA 30912 Phone: 678-790-0634 | |
Angela Overstreet Wright, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2607 Commons Blvd, Augusta, GA 30909 Phone: 706-750-8601 | |
Shahed Anam Ibn Faruk, Family Medicine Medicare: Medicare Enrolled Practice Location: 1120 15th St, Augusta, GA 30912 Phone: 706-721-2273 |